COVID oral antivirals

Dear VAPAC members,

Given the increasing supply of oral antivirals for Arizona, as well as the ability of pharmacy partners to meet demand with allotted supply, ADHS has approved moving into Tier 3 of the Antiviral Prioritization Criteria. As discussed during the VAPAC meeting on Jan. 7, 2022:

Tier 1 eligible patients include:

• Patients 70 years of age or older;
• OR who have major immune suppression (i.e., HIV, severe primary immunodeficiency, cancer and/or transplant patients,
• or patients on chronic steroids or other immunosuppressive drugs)

Tier 2 eligible patients include:

• Tier 1 and Age 50 years or older with one or more CDC high risk conditions for COVID-19 disease progression. Please see the complete list of CDC High Risk Health Conditions.

Tier 3 expands use for all eligible patients within the general population.

We will be sending this information via our Health Alert Network and will also share this with medical and pharmacy licensing boards.

 Please share this update widely among your colleagues and provider networks.

 We encourage your colleagues to visit our websites for updated information:

• azdhs.gov/mAbs
• azdhs.gov/antivirals
• azdhs.gov/findtreatment

Thank you,

ADHS HEOC Team
Arizona Department of Health Services
Health Emergency Operations Center (HEOC)
HEOC_vaccine@azdhs.gov
Health and Wellness for all Arizonans